Homocysteine as a Key Biomarker of Metabolic Stress During Foslevodopa/Foscarbidopa Infusion Therapy.
- DOI
- 10.1002/mds.70539
- Published
- 2026 Sep 23
- Container
- Movement disorders : official journal of the Movement Disorder Society
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/mds.70539,
title = {Homocysteine as a Key Biomarker of Metabolic Stress During Foslevodopa/Foscarbidopa Infusion Therapy.},
author = {Ory-Magne F and Frismand S and Drapier S and Baille G},
year = {2026},
journal = {Movement disorders : official journal of the Movement Disorder Society},
doi = {10.1002/mds.70539},
url = {https://doi.org/10.1002/mds.70539}
}RIS
TY - JOUR TI - Homocysteine as a Key Biomarker of Metabolic Stress During Foslevodopa/Foscarbidopa Infusion Therapy. AU - Ory-Magne F AU - Frismand S AU - Drapier S AU - Baille G PY - 2026 JO - Movement disorders : official journal of the Movement Disorder Society DO - 10.1002/mds.70539 UR - https://doi.org/10.1002/mds.70539 ER -
APA
F, O., S, F., S, D., & G, B. (2026). Homocysteine as a Key Biomarker of Metabolic Stress During Foslevodopa/Foscarbidopa Infusion Therapy.. Movement disorders : official journal of the Movement Disorder Society. https://doi.org/10.1002/mds.70539
Source records
- pubmed · retrieved 2026-09-24T21:20:10.313Z